Abstract

"Ivermectin for Early Treatment and Prophylaxis of COVID-19 When Exposed to Patients: Author’s Perspective"

Highlights

  • The world is currently facing a great challenge of the current COVID-19 pandemic that has swept the world’s population and affected all aspects of life including health and economic affairs

  • We tried to investigate the effect of ivermectin as a prophylaxis in close contacts of confirmed cases of COVID-19

  • Ivermectin is a safe, non-expensive and available drug. It has been previously approved by US FDA as a well-tolerable safe drug used previously for treatment and even mass prophylaxis of several parasitic drugs

Read more

Summary

Introduction

The world is currently facing a great challenge of the current COVID-19 pandemic that has swept the world’s population and affected all aspects of life including health and economic affairs. This forced many countries to take measures, including preventing popular gatherings and aspects of life in clubs, universities and schools, and closing their borders, in addition to taking physical distancing measures and wearing face masks to prevent the spread of infection [1]. We tried to investigate the effect of ivermectin as a prophylaxis in close contacts of confirmed cases of COVID-19.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call